569 related articles for article (PubMed ID: 16040409)
41. The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.
Krueger GG; Drake LA; Elias PM; Lowe NJ; Guzzo C; Weinstein GD; Lew-Kaya DA; Lue JC; Sefton J; Chandraratna RA
Arch Dermatol; 1998 Jan; 134(1):57-60. PubMed ID: 9449910
[TBL] [Abstract][Full Text] [Related]
42. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity.
Queille-Roussel C; Duteil L; Parneix-Spake A; Arsonnaud S; Rizova E
Eur J Dermatol; 2001; 11(3):219-24. PubMed ID: 11358728
[TBL] [Abstract][Full Text] [Related]
43. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
Kragballe K; Steijlen PM; Ibsen HH; van de Kerkhof PC; Esmann J; Sorensen LH; Axelsen MB
Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
[TBL] [Abstract][Full Text] [Related]
44. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S
Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128
[TBL] [Abstract][Full Text] [Related]
45. A randomized controlled trial to compare calcipotriol with betamethasone valerate for the treatment of cutaneous lichen planus.
Theng CT; Tan SH; Goh CL; Suresh S; Wong HB; Machin D;
J Dermatolog Treat; 2004 Jun; 15(3):141-5. PubMed ID: 15204145
[TBL] [Abstract][Full Text] [Related]
46. Comparison of clinical effects of psoriasis treatment regimens among calcipotriol alone, narrowband ultraviolet B phototherapy alone, combination of calcipotriol and narrowband ultraviolet B phototherapy once a week, and combination of calcipotriol and narrowband ultraviolet B phototherapy more than twice a week.
Takahashi H; Tsuji H; Ishida-Yamamoto A; Iizuka H
J Dermatol; 2013 Jun; 40(6):424-7. PubMed ID: 23414298
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
Ortonne JP; Kaufmann R; Lecha M; Goodfield M
Dermatology; 2004; 209(4):308-13. PubMed ID: 15539894
[TBL] [Abstract][Full Text] [Related]
48. Long-term treatment of psoriasis with calcipotriol scalp solution and cream.
Barnes L; Altmeyer P; Fôrstrôm L; Stenström MH
Eur J Dermatol; 2000; 10(3):199-204. PubMed ID: 10725818
[TBL] [Abstract][Full Text] [Related]
49. Concomitant treatment of psoriasis of the hands and feet with pulsed dye laser and topical calcipotriol, salicylic acid, or both: a prospective open study in 41 patients.
de Leeuw J; Tank B; Bjerring PJ; Koetsveld S; Neumann M
J Am Acad Dermatol; 2006 Feb; 54(2):266-71. PubMed ID: 16443057
[TBL] [Abstract][Full Text] [Related]
50. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
Ortonne JP; Humbert P; Nicolas JF; Tsankov N; Tonev SD; Janin A; Czernielewski J; Lahfa M; Dubertret L
Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387
[TBL] [Abstract][Full Text] [Related]
51. An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid.
Tanghetti EA;
Cutis; 2000 Dec; 66(6 Suppl):4-11. PubMed ID: 11147088
[TBL] [Abstract][Full Text] [Related]
52. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
53. Topical calcipotriol therapy in nail psoriasis: a study of 24 cases.
Zakeri M; Valikhani M; Mortazavi H; Barzegari M
Dermatol Online J; 2005 Dec; 11(3):5. PubMed ID: 16409901
[TBL] [Abstract][Full Text] [Related]
54. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
[TBL] [Abstract][Full Text] [Related]
55. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
Poulin YP
Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
[TBL] [Abstract][Full Text] [Related]
56. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
Weinstein GD; Koo JY; Krueger GG; Lebwohl MG; Lowe NJ; Menter MA; Lew-Kaya DA; Sefton J; Gibson JR; Walker PS;
J Am Acad Dermatol; 2003 May; 48(5):760-7. PubMed ID: 12734506
[TBL] [Abstract][Full Text] [Related]
57. [New treatment of psoriasis with the vitamin D analogue calcipotriol].
Austad J
Tidsskr Nor Laegeforen; 1993 Nov; 113(29):3580-1. PubMed ID: 8273098
[TBL] [Abstract][Full Text] [Related]
58. Calcipotriol. A new topical antipsoriatic.
Kragballe K; Iversen L
Dermatol Clin; 1993 Jan; 11(1):137-41. PubMed ID: 8435908
[TBL] [Abstract][Full Text] [Related]
59. Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
Peeters P; Ortonne JP; Sitbon R; Guignard E
Dermatology; 2005; 211(2):139-45. PubMed ID: 16088161
[TBL] [Abstract][Full Text] [Related]
60. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
Claréus BW; Houwing R; Sindrup JH; Wigchert S
Eur J Dermatol; 2009; 19(6):581-5. PubMed ID: 19726275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]